Furosemide Approved to Treat Edema in CKD

The FDA approved a supplemental New Drug Application (sNDA) for furosemide (Furoscix), expanding the drug’s indication to include treatment of edema in patients with chronic kidney disease (CKD).

Furosemide, a loop diuretic administered by subcutaneous infusion, was previously approved to treat edema in adults with chronic heart failure.

“We are excited to introduce Furoscix to nephrologists and are focused on providing treatment options to both heart failure and CKD patients experiencing acute fluid overload,” said John Tucker, CEO of drug maker scPharmaceuticals Inc.

Source: Press release